{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:18:42Z","timestamp":1747196322311,"version":"3.40.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,13]]},"DOI":"10.7759\/cureus.84029","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:36:22Z","timestamp":1747150582000},"source":"Crossref","is-referenced-by-count":0,"title":["Substance Use Treatment Services in New York (2021\u20132023): A State Profile Analysis Based on National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) Data"],"prefix":"10.7759","author":[{"given":"Abimbola  E","family":"Arisoyin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther  I","family":"Ezeani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edediong","family":"Ekarika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaka S","family":"Odega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar O","family":"Ahumaraeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okelue E","family":"Okobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000271","article-title":"Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments","volume":"28","author":"Connery HS","year":"2020","unstructured":"Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance use disorders in global mental health delivery: epidemiology, treatment gap, and implementation of evidence-based treatments. Harv Rev Psychiatry. 2020, 28:316-27. 10.1097\/HRP.0000000000000271","journal-title":"Harv Rev Psychiatry"},{"key":"ref2","article-title":"Effects of medication-assisted treatment (MAT) for opioid use disorder on functional outcomes: a systematic review","volume":"8","author":"Maglione MA","year":"2020","unstructured":"Maglione MA, Raaen L, Chen C, et al.. Effects of medication-assisted treatment (MAT) for opioid use disorder on functional outcomes: a systematic review. Rand Health Q. 2020, 8:RR-2108-OSD.","journal-title":"Rand Health Q"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.IJCM_998_20","article-title":"Improving treatment of substance use disorders through community drug treatment clinics: an experiential account","volume":"46","author":"Rao R","year":"2021","unstructured":"Rao R, Dhawan A, Parmar A, Yadav D, Bhad R. Improving treatment of substance use disorders through community drug treatment clinics: an experiential account. Indian J Community Med. 2021, 46:370-3. 10.4103\/ijcm.IJCM_998_20","journal-title":"Indian J Community Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01045-3","article-title":"Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State","volume":"21","author":"Kruger DJ","year":"2024","unstructured":"Kruger DJ, Kirk HM, Leonard KE, et al.. Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State. Harm Reduct J. 2024, 21:134. 10.1186\/s12954-024-01045-3","journal-title":"Harm Reduct J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","year":"2018","unstructured":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018, 5:987-1012. 10.1016\/S2215-0366(18)30337-7","journal-title":"Lancet Psychiatry"},{"key":"ref6","article-title":"Drug addiction","author":"Fluyau D","year":"2025","unstructured":"Fluyau D, Hashmi MF, Charlton TE. Drug addiction. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref7","unstructured":"Drug addiction (substance use disorder). (2022). Accessed. January 18, 2025: https:\/\/www.mayoclinic.org\/diseases-conditions\/drug-addiction\/symptoms-causes\/syc-20365112."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"McHugh RK","year":"2010","unstructured":"McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010, 33:511-25. 10.1016\/j.psc.2010.04.012","journal-title":"Psychiatr Clin North Am"},{"key":"ref9","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). Accessed. January 28, 2025: https:\/\/www.samhsa.gov\/data\/."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000400","article-title":"Gaps in the substance use disorder treatment referral process: provider perceptions","volume":"12","author":"Blevins CE","year":"2018","unstructured":"Blevins CE, Rawat N, Stein MD. Gaps in the substance use disorder treatment referral process: provider perceptions. J Addict Med. 2018, 12:273-7. 10.1097\/ADM.0000000000000400","journal-title":"J Addict Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/02537176211067570","article-title":"Role of mental health non-governmental organizations (MHNGOs) in realizing the objectives of the Mental Healthcare Act (MHCA) 2017","volume":"45","author":"Visalakshi S","year":"2023","unstructured":"Visalakshi S, Prateek V, Kamaldeep S, et al.. Role of mental health non-governmental organizations (MHNGOs) in realizing the objectives of the Mental Healthcare Act (MHCA) 2017. Indian J Psychol Med. 2023, 45:69-75. 10.1177\/02537176211067570","journal-title":"Indian J Psychol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304094","article-title":"Examining facilitative services for entry into substance use disorder treatment: a cluster analysis of treatment facilities","volume":"19","author":"Amoako EO","year":"2024","unstructured":"Amoako EO, Zerden LD, Hughes TD, Gertner AK, Williams J, Belden CM, Ware OD. Examining facilitative services for entry into substance use disorder treatment: a cluster analysis of treatment facilities. PLoS One. 2024, 19:e0304094. 10.1371\/journal.pone.0304094","journal-title":"PLoS One"},{"key":"ref13","article-title":"Trends in the use of Methadone, Buprenorphine, and Extended-Release Naltrexone at substance abuse treatment facilities: 2003-2015","author":"Alderks CE","year":"2017","unstructured":"Alderks CE. Trends in the use of Methadone, Buprenorphine, and Extended-Release Naltrexone at substance abuse treatment facilities: 2003-2015. Substance Abuse and Mental Health Services Administration (US), Rockville (MD); 2017."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds","volume":"3","author":"Whelan PJ","year":"2012","unstructured":"Whelan PJ, Remski K. Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds. J Neurosci Rural Pract. 2012, 3:45-50. 10.4103\/0976-3147.91934","journal-title":"J Neurosci Rural Pract"},{"key":"ref15","article-title":"Naltrexone","author":"Singh D","year":"2025","unstructured":"Singh D, Saadabadi A. Naltrexone. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.030","article-title":"Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study","volume":"150","author":"Weiss RD","year":"2015","unstructured":"Weiss RD, Potter JS, Griffin ML, et al.. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015, 150:112-9. 10.1016\/j.drugalcdep.2015.02.030","journal-title":"Drug Alcohol Depend"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.110.031831","article-title":"Contingency management: what it is and why psychiatrists should want to use it","volume":"35","author":"Petry NM","year":"2011","unstructured":"Petry NM. Contingency management: what it is and why psychiatrists should want to use it. Psychiatrist. 2011, 35:161-3. 10.1192\/pb.bp.110.031831","journal-title":"Psychiatrist"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2021.100117","article-title":"Telemedicine for healthcare: capabilities, features, barriers, and applications","volume":"2","author":"Haleem A","year":"2021","unstructured":"Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021, 2:100117. 10.1016\/j.sintl.2021.100117","journal-title":"Sens Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104567","article-title":"Expert providers implement integrated and coordinated care in opioid use disorder treatment","volume":"132","author":"Harris LM","year":"2024","unstructured":"Harris LM, Guerrero EG, Khachikian T, Serrett V, Marsh JC. Expert providers implement integrated and coordinated care in opioid use disorder treatment. Int J Drug Policy. 2024, 132:104567. 10.1016\/j.drugpo.2024.104567","journal-title":"Int J Drug Policy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63881","article-title":"Revolutionizing healthcare: how telemedicine is improving patient outcomes and expanding access to care","volume":"16","author":"Ezeamii VC","year":"2024","unstructured":"Ezeamii VC, Okobi OE, Wambai-Sani H, et al.. Revolutionizing healthcare: how telemedicine is improving patient outcomes and expanding access to care. Cureus. 2024, 16:e63881. 10.7759\/cureus.63881","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmhs.2024.100039","article-title":"Assessing challenges and solutions in substance abuse prevention, harm reduction, and treatment services in New York State","volume":"3","author":"Kruger DK","year":"2024","unstructured":"Kruger DK, Kirk HM, Leonard KE, Lynch JJ, Nielsen N, Clemency BM. Assessing challenges and solutions in substance abuse prevention, harm reduction, and treatment services in New York State. SSM Health . 2024, 3:100039. 10.1016\/j.ssmhs.2024.100039","journal-title":"SSM Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000789","article-title":"Discontinuing methadone and buprenorphine: a review and clinical challenges","volume":"15","author":"Zweben JE","year":"2021","unstructured":"Zweben JE, Sorensen JL, Shingle M, Blazes CK. Discontinuing methadone and buprenorphine: a review and clinical challenges. J Addict Med. 2021, 15:454-60. 10.1097\/ADM.0000000000000789","journal-title":"J Addict Med"},{"key":"ref23","unstructured":"Utah Medicaid Dur Report February 2024 Persistence on sublocade (Buprenorphine extended-release injection) for opioid use disorder. A retrospective review. (2024). Accessed: January 6, 2025: https:\/\/medicaid.utah.gov\/pharmacy\/drugutilization\/files\/Criteria%20Review%20Documents\/2024\/2024.02%20Sublocade%20Per...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342064-substance-use-treatment-services-in-new-york-2021-2023-a-state-profile-analysis-based-on-national-survey-of-substance-abuse-and-mental-health-services-n-sumhss-data","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:36:25Z","timestamp":1747150585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342064-substance-use-treatment-services-in-new-york-2021-2023-a-state-profile-analysis-based-on-national-survey-of-substance-abuse-and-mental-health-services-n-sumhss-data"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.84029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}